Atlas Trials

Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients

Clinical trial NCT01262456 · COMPLETED

Trial details

NCT number
NCT01262456
Sponsor
Ferring Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Nocturia
Start date
2011-02-01
Primary completion
2012-01-01
Enrollment
395

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.